Philips Ventilator Recall

If you or a loved one use a Philips sleep apnea machine or ventilator and suffered a serious health complication, contact Johnson Firm for more information.

We offer free, no obligation consultations. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated attorney who can assist you throughout the legal process.

Get a Free Case Review

The Philips Ventilator Recall: An Overview

In June 2021, the Dutch medical equipment company Philips issued a voluntary recall for certain sleep apnea machines and ventilators that contained a polyester-based polyurethane (PE-PUR) sound abatement foam component. The recall was initiated due to concerns that the foam component could degrade over time and become toxic, posing potential health risks to patients.

Understanding Sleep Apnea

Sleep apnea, a common condition characterized by abnormal or infrequent breathing during sleep, can be classified into two types: Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA). OSA is caused by a physical obstruction in the throat, leading to reduced or halted airflow, whereas CSA stems from an underlying neurological condition affecting the brain signals or muscles responsible for breathing.

The time you have to pursue a claim is limitedCall Today: (501) 777-7777

Identifying and Treating Sleep Apnea

Typical symptoms of sleep apnea include disrupted breathing, excessive daytime sleepiness, morning headaches, irritability, limited attention span, and difficulty thinking clearly. The condition is usually managed through a personalized plan developed with a healthcare provider, and may include lifestyle changes or the use of breathing devices like positive airway pressure (PAP) machines, continuous positive airway pressure (CPAP) machines, mouthpieces, or implants.

Comprehensive Details of the Philips Ventilator Recall

The 2021 Philips ventilator recall encompasses specific sleep apnea machines and ventilators containing a PE-PUR sound abatement foam component. This includes Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices. The concern is that the foam may degrade into particles that could be inhaled or ingested by the user or it might release potentially harmful chemicals through off-gassing. Despite no reported deaths related to these issues, Philips has acknowledged potential patient impact due to foam degradation, with risks including headaches, irritation, inflammation, respiratory issues, and possible toxic and carcinogenic effects.

Get a Free Case Review

Get Help Now.